China Nuokang Bio-Pharmaceutical Inc. Announces Participation in Upcoming Conferences
May 07, 2010 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, May 7, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
March 16, 2010 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
Baquting Sales Drive Strong 4Q09 Revenue and Net Income Performance
4Q09 Revenue up 15.3% to RMB82.9 Million YOY
4Q09 Non-GAAP Net Income as Adjusted up 30.9% to RMB30.6 Million YOY...
China Nuokang Bio-Pharmaceutical Inc. to Report Fourth Quarter and Full Year 2009 Financial Results
March 09, 2010 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, March 9, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Announces Pricing of Initial Public Offering on the NASDAQ Global Market
December 09, 2009 23:36 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Dec. 9, 2009 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...